Cargando…
High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia
We present retrospectively our experience in the use of high-dose chemotherapy and haematopoietic stem cell support (HSCS) for refractory gestational trophoblastic neoplasia (GTN) in the largest series so far reported. In all, 11 patients have been treated at three Trophoblast Centres between 1993 a...
Autores principales: | El-Helw, L M, Seckl, M J, Haynes, R, Evans, L S, Lorigan, P C, Long, J, Kanfer, E J, Newlands, E S, Hancock, B W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361618/ https://www.ncbi.nlm.nih.gov/pubmed/16222307 http://dx.doi.org/10.1038/sj.bjc.6602771 |
Ejemplares similares
-
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours
por: McNeish, I A, et al.
Publicado: (2004) -
A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
por: Powles, T, et al.
Publicado: (2007) -
Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate?
por: Powles, T, et al.
Publicado: (2006) -
Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide
por: Braga, Antonio, et al.
Publicado: (2019) -
The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours
por: Blagden, S P, et al.
Publicado: (2002)